Momentum: MACD histogram positive (0.177) and expanding, supporting continuation strength.
RSI(6): 73.43 (elevated), suggesting the stock is getting stretched in the short term.
Levels: Pivot support ~19.57; S1 ~18.58. Resistance: R1 ~20.56 (very close to current), then R2 ~21.18.
Pattern-based expectation: ~60% odds point to flat-to-slightly down next day/week (-0.19%/-0.22%) but positive next month (+5.9%), implying near-term churn after a run-up.
Net Income: 2.210M (-426.92% YoY), major profitability decline.
EPS: 0.32 (-420.00% YoY), consistent with the earnings drop.
Gross Margin: 16.64 (+3.42% YoY), margin improved but did not translate into higher bottom-line profit.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data provided, so no identifiable recent Wall Street trend.
Practical pros view (inferred from available data): strong revenue growth and bullish technicals.
Practical cons view (inferred from available data): sharp YoY earnings decline and an extended short-term technical setup near resistance.
Politicians/congress: No recent congress trading data available (last 90 days).
Wall Street analysts forecast FRD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FRD is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast FRD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FRD is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
